HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lacrimal gland malignant mixed tumors (carcinomas arising in benign mixed tumors): a clinico-pathologic study.

Abstract
Six cases of a rare entity, lacrimal gland malignant mixed tumor (MMT), or carcinoma arising in benign mixed tumor (BMT), are presented. Clinically, 2 patients had a long history of orbital protrusion, which recently had progressed more rapidly, In 2 other cases, the carcinomas evolved after recurrences of BMT. Two other patients experienced the recent onset of symptoms, without a known tumor previously having been present. Clinical clues suggesting a malignant neoplasm of a lacrimal gland include 1) recent rapid onset of symptoms (orbital protrusion, eyelid swelling; 2) presence of pain; and 3) radiographic studies showing bone destruction. In each of our cases, histologic examination demonstrated a BMT as well as a carcinoma (undifferentiated or poorly differentiated adenocarcinoma; in 1 case, areas of adenoid cystic carcinoma were identified). Problems in histopathologic diagnosis are explored. (BMT, recurrent BMT, in situ carcinoma in BMT and MMT are differentiated.) The management of lacrimal gland tumors is discussed. For a suspected malignant neoplasm, a biopsy through the eye lid to establish the diagnosis is recommended. Radical orbital exenteration should be performed for malignant mixed tumors, which have a poor prognosis.
AuthorsK H Perzin, F A Jakobiec, V A Livolsi, L Desjardins
JournalCancer (Cancer) Vol. 45 Issue 10 Pg. 2593-2606 (May 15 1980) ISSN: 0008-543X [Print] United States
PMID7378993 (Publication Type: Case Reports, Comparative Study, Journal Article)
Topics
  • Adenoma (pathology)
  • Adult
  • Aged
  • Eye Neoplasms (pathology)
  • Female
  • Humans
  • Lacrimal Apparatus Diseases (pathology)
  • Male
  • Middle Aged
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: